The Diagnostic Pitfalls and Clinical Challenges of Unilateral Facial Paralysis in Acute Demyelinating Disorders: A Case Report and Literature Review
Thamer Alhowaish1, Hossam Alqahtani1, Moustafa Alhamadh2, Ali Alanazi1
1Department of Neurology, Ministry of National Guard-Health Afairs, Riyadh, Saudi Arabia, 2King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
Objective:

To describe an atypical presentation of Guillain–Barré syndrome (GBS) manifesting as unilateral facial palsy, a rare variant that can closely mimic Bell’s palsy and delay appropriate diagnosis and treatment

Background:
GBS is an acute, immune-mediated polyradiculoneuropathy typically characterized by progressive, symmetric limb weakness and areflexia. Although bilateral facial nerve palsy is well recognized, unilateral involvement is exceedingly uncommon and may obscure the underlying diagnosis.
Design/Methods:
We report the case of a previously healthy 32-year-old man who presented with ascending paresthesias and acute right-sided lower motor neuron facial weakness following an upper respiratory tract infection.
Results:

The illness began with subtle fingertip numbness ascending to the elbows, followed by rapid progression to perioral numbness, dysarthria, and inability to close the right eye. On initial examination, he had diminished deep tendon reflexes but preserved muscle strength and sensation. Within several days, his reflexes became globally absent. Cerebrospinal fluid analysis revealed albuminocytologic dissociation. Initial electrophysiologic studies were unremarkable for cranial nerve involvement; however, repeat testing demonstrated bilateral facial and trigeminal neuropathies consistent with a demyelinating GBS variant. The patient was treated with intravenous immunoglobulin, resulting in marked improvement of facial weakness. 

Conclusions:

This case highlights a rare but clinically important variant of Guillain–Barré syndrome presenting with unilateral facial palsy, an atypical manifestation that can be mistaken for idiopathic Bell’s palsy. Such overlap in presentation may delay recognition of the underlying immune-mediated neuropathy and postpone initiation of therapy. Awareness of this variant is essential, particularly when facial weakness develops after a recent infectious illness. Early identification of Guillain–Barré syndrome allows timely initiation of immunotherapy, which can improve outcomes. Clinicians should therefore consider GBS in the differential diagnosis of acute cranial neuropathies, even when the presentation resembles more common entities such as Bell’s palsy. Prompt diagnosis and management are crucial to prevent disease progression and complications, including respiratory involvement.

10.1212/WNL.0000000000216338
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.